Skip to Content Skip to Content

Fulbright 2023 U.S. Student Program grants awarded to 29 Penn affiliates

Twenty-nine University of Pennsylvania students, recent graduates, and alumni have been offered Fulbright grants for the 2023-24 academic year to conduct research, pursue graduate degrees, or teach English in more than 20 nations. 
29 people in a grid
Twenty-nine Penn students, recent graduates, and alumni have been offered Fulbright grants for the 2023-24 academic year, from left: (top row) Anuj Amin, Ella Atsavapranee, Rebecca Bean, Rachael (Viola) Bordon, Erin Brennan, Mia Cheung; (second row) Allison Chou, Teresa Christensen, Sabrina de Brito, Ashley Fuchs, Zacharia Hamdi, Nilesh Kavthekar; (third row) Vincent Kelley, Lauren Lamb, Esther Lee, Beyoncé Lightfoot, Colin Lodewick, Lea Mangifesta; (fourth row) Vanessa Martinez Penn, Anya Miller, Marissa Mojena, Priyamvada Nambrath, Trevor Núñez, Sriram Palepu; (bottom row) Kyra Schulman, Laila Shadid, Ingrid Sotelo, Sally Thomas, and Erin Wrightson. 
(Images: Courtesy of the Center for Undergraduate Research and Fellowships) 

Recent Articles

  • More Articles
  • The Fed explained: What it does and why it matters
    Photo of the Federal Reserve facade

    (Image: Lance Nelson)

    The Fed explained: What it does and why it matters

    Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy

    May 13, 2026

    Fighting oral cancer with bioengineered chewing gum
    A latex-gloved hand hoding a petri dish of medical chewing gum.

    A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.

    (Image: Kevin Monko/Penn Dental Medicine)

    Fighting oral cancer with bioengineered chewing gum

    Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.

    Apr 20, 2026